The Toronto Stock Exchange reports that it is reviewing the common shares of Willow Biosciences Inc. According to the TSX, the company has 120 days to regain compliance with its continued listing requirements, pursuant to the remedial delisting review.
© 2025 Canjex Publishing Ltd. All rights reserved.